Detalles de la búsqueda
1.
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Gastric Cancer;
24(4): 926-936, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33651195
2.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Gastric Cancer;
24(2): 445-456, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32970266
3.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Ther Adv Med Oncol;
15: 17588359231157641, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895850
4.
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.
Thromb Haemost;
122(10): 1653-1661, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381615
5.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Ther Adv Med Oncol;
13: 17588359211019672, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34211587
6.
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
PLoS One;
15(7): e0235848, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32735623
7.
Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
Front Genet;
10: 439, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31156702
8.
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Thromb Haemost;
119(11): 1849-1859, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31461750
Resultados
1 -
8
de 8
1
Próxima >
>>